-
公开(公告)号:US12235265B2
公开(公告)日:2025-02-25
申请号:US16308145
申请日:2017-06-08
Applicant: Denka Company Limited
Inventor: Daisuke Kato , Tomohiro Hattori , Shino Muramatsu
IPC: G01N33/543 , G01N1/40 , G01N33/569
Abstract: The present invention relates to an immunochromatography test method of measuring a sugar chain antigen, which provides an immunochromatographic test piece and a specimen adding device capable of specifically measuring a sugar chain antigen, and an immunochromatography method using the same; wherein after mixing a specimen with a nitrite solution, a step of allowing tartaric acid to come into contact with the mixture, and extracting a sugar chain antigen contained in the specimen is carried out in a filtration step.
-
公开(公告)号:US12235262B1
公开(公告)日:2025-02-25
申请号:US17014909
申请日:2020-09-08
Applicant: 10X GENOMICS, INC.
Inventor: Paul Giresi
IPC: G01N33/543 , G01N33/68
Abstract: Provided herein are methods identifying protein-protein interactions in a single cell context. In some cases, the methods may be used to measure the abundance of protein-protein interactions in a single cell context. In some cases, the methods may be used to map relationships (e.g., spatial relationships) between proteins in a single cell context. Generally, the methods employ the use of proximity probes coupled with splint oligonucleotides to link information about the relationship of proteins within a single cell context, which may then be read in a downstream process (e.g., a sequencing reaction).
-
公开(公告)号:US12233407B2
公开(公告)日:2025-02-25
申请号:US18161322
申请日:2023-01-30
Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor: Dino Di Carlo , Chueh-Yu Wu
IPC: B01L3/02 , B01L3/00 , C12N1/04 , C12N5/071 , C12N5/0783 , C12Q1/6806 , G01N33/543
Abstract: Sub-millimeter scale three-dimensional (3D) structures are disclosed with customizable chemical properties and/or functionality. The 3D structures are referred to as drop-carrier particles. The drop-carrier particles allow the selective association of one solution (i.e., a dispersed phased) with an interior portion of each of the drop-carrier particles, while a second non-miscible solution (i.e., a continuous phase) associates with an exterior portion of each of the drop-carrier particles due to the specific chemical and/or physical properties of the interior and exterior regions of the drop-carrier particles. The combined drop-carrier particle with the dispersed phase contained therein is referred to as a particle-drop. The selective association results in compartmentalization of the dispersed phase solution into sub-microliter-sized volumes contained in the drop-carrier particles. The compartmentalized volumes can be used for single-molecule assays as well as single-cell, and other single-entity assays.
-
公开(公告)号:US20250060363A1
公开(公告)日:2025-02-20
申请号:US18934777
申请日:2024-11-01
Applicant: Siemens Healthcare Diagnostics Inc.
Inventor: Spencer Lin , Christopher Reamer , Ryan Spears
IPC: G01N33/531 , G01N33/52 , G01N33/536 , G01N33/543
Abstract: Processes for quantifying an amount of functional groups immobilized on a solid support are described herein. The processes allow for determining whether sufficient functional groups are provided on a solid support for the attachment of a first binding pair member for the detection of a target analyte.
-
公开(公告)号:US12228584B2
公开(公告)日:2025-02-18
申请号:US17506600
申请日:2021-10-20
Applicant: XCella Biosciences, Inc.
Inventor: Bob Chen
IPC: G01N35/10 , B01J19/00 , B01L3/00 , B01L9/00 , C12N15/10 , C12Q1/6851 , C40B60/02 , G01N15/14 , G01N15/1433 , G01N21/75 , G01N33/543 , G01N15/10 , G01N21/03 , G01N21/64 , G01N21/77 , G01N35/00
Abstract: Multi-stage sample-recovery systems, including automated 2-stage and 3-stage sample-recovery systems, are provided. Such systems enable the rapid screening and recovery of samples, including viable cell-based samples, from high-throughput screening systems, including systems utilizing large-scale arrays of microcapillaries. In specific screening systems, each microcapillary comprises a solution containing a variant protein, an immobilized target molecule, and a reporter element. Immobilized target molecules may include any molecule of interest, including proteins, nucleic acids, carbohydrates, and other biomolecules. The association of a variant protein with a molecular target is assessed by measuring a signal from the reporter element. The contents of microcapillaries identified in the assays as containing variant proteins of interest can be identified and recovered using the multi-stage systems disclosed herein.
-
公开(公告)号:US12228545B2
公开(公告)日:2025-02-18
申请号:US18455401
申请日:2023-08-24
Applicant: PRINCETON BIOCHEMICALS, INC
Inventor: Norberto A. Guzman
IPC: G01N27/447 , G01N1/40 , G01N33/543 , G01N33/561
Abstract: A diagnostic and prognostic method and system for sequentially analyzing in a biological fluid or tissue extract the presence of an antigenic infectious agent, infectious organism or its toxic product; an antibody response to the antigenic infectious agent, infectious organism or its toxic product; one or more biomarkers formed during infection in response to a communicable disease; and one or more biomarkers to assess the severity of the disease and to monitor the effectiveness of drug therapy or vaccination.
-
公开(公告)号:US12216116B2
公开(公告)日:2025-02-04
申请号:US17579528
申请日:2022-01-19
Applicant: CORNELL UNIVERSITY
Inventor: Sasank Vemulapati , David Erickson
IPC: G01N33/543 , G01N1/40 , G01N33/569
Abstract: The present disclosure relates to, inter alia, devices, systems, and methods for use in the magnetic separation of biological entities from fluid samples. This device includes a magnetic separation chamber configured to receive a fluid sample for magnetic separation, where the magnetic separation chamber includes at least two magnets mounted on the surface or in the wall of the magnetic separation chamber. The device also includes a force provider configured to move the magnetic separation chamber in a side-to-side motion to mix and/or magnetize the fluid sample. In one embodiment, the magnetic separation chamber is in a form of a sleeve and comprises a substantially central channel for loading a vessel containing the fluid sample therein. The systems and methods of the present disclosure involve the use of this device to separate biological entities from fluid samples.
-
公开(公告)号:US12214351B2
公开(公告)日:2025-02-04
申请号:US17546440
申请日:2021-12-09
Applicant: ORASURE TECHNOLOGIES, INC.
Inventor: Mark Fischl , Keith Kardos , Attila Nemeth , Mark Emrick
IPC: B01L3/00 , G01N33/543
Abstract: The invention provides a developer solution vial and methods of its use to diagnose diseases using a sampling and/or assay device, for example, for use with a lateral flow assay (LFA) device. The developer solution vial may include any container that is capable of holding developer solution. The developer solution vial is keyed to the sampling and/or assay device. The developer solution vial minimizes the amount of developer solution required for accurate fluid flow assay testing.
-
公开(公告)号:US20250035622A1
公开(公告)日:2025-01-30
申请号:US18763140
申请日:2024-07-03
Inventor: Kabir H. Biswas , Asma Fatima , Anupriya M. Geethakumari
IPC: G01N33/543 , G01N33/569
Abstract: A biosensor for detecting proteolytic cleavage activity of two proteases, coronavirus main protease (Mpro) and papain-like protease (PLpro) is provided. The biosensor utilizes Bioluminescence Resonance Energy Transfer (BRET) between a donor and two acceptor moieties.
-
公开(公告)号:US20250035618A1
公开(公告)日:2025-01-30
申请号:US18709250
申请日:2022-12-27
Applicant: SEKISUI MEDICAL CO., LTD.
Inventor: Daisuke YAMADA , Ikumi SUZUKI , Kengo FUJIMURA , Tomohide ASAI , Osamu MIYAZAKI
IPC: G01N33/543 , G01N33/53 , G01N33/536
Abstract: It is an object of the present invention to provide a method for suppressing non-specific reactions using a highly versatile method without affecting specific reactions. The present invention provides a detection method for detecting a target antigen in a sample using a specific antibody that specifically binds to the antigen, the method comprising: a) a step of bringing the sample into contact with a modified antibody; and b) a step of bringing the sample into contact with the specific antibody simultaneously with or after the step a), which is a highly versatile method that can suppress non-specific reactions.
-
-
-
-
-
-
-
-
-